Valued at USD 4.86 billion in 2024, the protein characterization and identification market is projected to reach USD 5.11 billion in 2025 and USD 8.05 billion by 2034, growing at a CAGR of 5.2% during the forecast period 2025–2034. Rapid technological advancements are enabling better research techniques, while the growth of the biologics and proteomics industries continues to broaden demand. Leading participants include Agilent Technologies, Thermo Fisher Scientific, Bruker Corporation, Danaher Corporation, and Waters Corporation.
R&D Spending Anchors Demand
Drug discovery and development is expected to be the most significant revenue contributor to the protein characterization and identification market, a position it holds and is expected to retain through the forecast period. Protein analysis is a crucial stage in developing pharmaceutical and biological products, helping identify viable candidates. The segment is expanding because of rising R&D spending and an increase in the number of clinical trials for advanced medicines.
According to the US Congressional Budget Office, the pharmaceutical sector spent USD 83 billion on research and development in 2019, and the FDA approved an average of 38 new drugs per year from 2010 through 2019, which is 60% more than the previous decade’s average. The biopharmaceutical market as a whole spent an estimated USD 102 billion on R&D. One new procedure takes 10–15 years and costs USD 2.6 billion, excluding the expense of failures, and only 12% of new molecular entities entering clinical trials are approved by the FDA.
Browse Insights:
End-User Leadership and Precision Medicine
The pharmaceutical and biotechnology companies segment held the largest end-use share, driven by rising demand for personalized medicine and biomarkers globally. A rising number of chronic and rare diseases is fueling demand for personalized medicine, and companies need protein identification and quantification for biomarker discovery, monitoring therapeutic responses, and supporting diagnostic tests. Rising investment in pharmaceutical and biotechnology companies further supports spending on services and tests. Academic research institutes and contract research organizations are the other major end users. Industry dynamics point to three tailwinds: rising R&D spending, a growing number of strategic product launches, partnerships, and collaborations, and continuing technological advancement.
Instrumentation and Product Innovation
By product and services, the protein characterization and identification market spans consumables, instruments, and services. Instrument categories include mass spectrometry instruments, chromatography, electrophoresis, label-free detection, and spectroscopy systems. Product launches, partnerships, and collaborations are boosting expansion. The report segments the market by product and services, application, end use, and region, with a regional scope covering North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
In June 2021, Thermo Fisher Scientific launched the Orbitrap IQ-X Tribrid mass spectrometer, created for small-molecule structure elucidation of compounds and unknown chemicals. Its applications include metabolomics, lipidomics, detection of leachable and extractable contaminants, and forensic toxicology. Launches of mass spectrometry instruments such as this are boosting market growth for protein identification and characterization.
Regional Outlook
North America recorded the highest revenue share in 2024, supported by prominent players, government financing for breakthrough technologies, and increased R&D spending in proteomics. In August 2021, Metrohm USA and Canada signed a partnership agreement with Agilent to resell its products and services. Asia Pacific is expected to witness a high CAGR during the forecast period, driven by rising chronic disease frequency. The first Longitudinal Ageing Study in India found that two of every three older adults suffer from a chronic condition, and diabetes affects 14% of those over 60.
Key Players and Market Restraints
Major players in the protein characterization and identification market include Agilent Technologies, Analytik Jena, Bio-Rad Laboratories, Bruker Corporation, Cleaver Scientific, Danaher Corporation, Eurofins Scientific, Horiba, Jeol, Merck KGaA, PerkinElmer, Promega Corporation, Qiagen, Sartorius AG, Shimadzu Corporation, Thermo Fisher Scientific, and Waters Corporation. The high cost of the instruments used for detection, identification, and characterization remains a major restraint on global demand.
More Trending Latest Reports By Polaris Market Research:
viral-vector-plasmid-dna-manufacturing-market
distributed-energy-resource-management-system-market